METH promotes liver cancer progression by ROS induction–mediated Ras up-regulation, which activates the MEK/ERK signaling pathway, whereas NAC reverses these effects via ROS clearance (Fig 8). The gene discussed is MAP2K7; the disease is liver cancer.